Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ferrous ascorbate + folic acid (Ind-Blues Pharma)
- Development stage
- Unknown
- Lead developer
- Ind Blues Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Rerifer is a brand of hematinic supplements developed and marketed by Ind Blues Pharma, primarily used for the prevention and treatment of iron deficiency anemia and nutritional deficiencies, particularly during pregnancy or recovery from blood loss. The product line includes several formulations: Rerifer tablets, which contain a combination of ferrous ascorbate (a highly bioavailable oral iron salt) and folic acid (vitamin B9); Rerifer Oral Suspension and Rerifer-CT chewable tablets, which contain ferrous calcium citrate and folic acid; and Rerifer Drops, which contain elemental iron and folic acid. These active ingredients work synergistically to restore depleted iron stores, support the synthesis of hemoglobin, and promote the production of healthy red blood cells, thereby improving oxygen transport throughout the body and alleviating symptoms of fatigue and weakness.
- Brand names
- ReriferRerifer CTRerifer DropsRerifer Oral SuspensionRerifer-Syrup
- Other names
- ferrous ascorbate and folic acidferrous calcium citrate and folic acidiron and folic acid
02
Targets
DHFR (Dihydrofolate reductase)FOLR1 (FRα)TFRC (Transferrin Receptor)
Beyond the preview
Go deeper on ferrous ascorbate + folic acid (Ind-Blues Pharma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ferrous ascorbate + folic acid (Ind-Blues Pharma).